Human papillomavirus 18 genetic variation and cervical cancer risk worldwide

Journal of Virology

Volumn 89, Issue 20, 2015, Pages 10680-10687

  Chen, Alyce A ^a,b   Gheit, Tarik ^a   Franceschi, Silvia ^a   Tommasino, Massimo ^a   Clifford, Gary M ^a   Munoz N ^a   Herrero, R ^a   Bosch, X ^a   Hammouda, D ^c   Loria, D ^c   Matos, E ^c   Tshomo, U ^c   Rios Dalenz, J L ^c   Eluf Neto, J ^c   Ghadirian, P ^c   Ferreccio, C ^c   Ojeda, J M ^c   Dai, M ^c   Li, L K ^c   Wu, R F ^c   Torroella, M ^c   Pearce, N ^c   Alibegashvili, T ^c   Kordzaia, D ^c   Keita, N ^c   Koulibaly, M ^c   Rajkumar, T ^c   Rajkumar, R ^c   Sarjadi, ^c   Khodakarami, N ^c   Gichangi, P ^c   De Vuyst, H ^c   Lee, D H ^c   Shin, H R ^c   Bayo, S ^c   Dondog, B ^c   Chaouki, N ^c   Sherpa, A T L ^c   Thomas, J O ^c   de los Rios, E ^c   Rolon, P A ^c   Caceres, E ^c   Santos, C ^c   Ngelangel, C ^c   Bardin, A ^c   Zatonski, W ^c   Ngabo, F ^c   Gatera, M ^c   Moodley, D ^c   de Sanjose, S ^c   Castellsague, X ^c   Kitinya, J N ^c   Chichareon, S ^c   Tunsakul, S ^c   Wabinga, H R ^c   Aruhuri, B ^c   Frazer, I H ^c   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NONE   (Vanuatu)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENICITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; NONHUMAN; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; ETHNOLOGY; GENETICS; GENOTYPE; HEALTH CARE FACILITY; MOLECULAR TYPING; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PHYLOGEOGRAPHY; RISK; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN;

ADENOCARCINOMA; BIOLOGICAL SPECIMEN BANKS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; DNA-BINDING PROTEINS; FEMALE; GENETIC VARIATION; GENOTYPE; HUMAN PAPILLOMAVIRUS 18; HUMANS; MOLECULAR TYPING; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PHYLOGEOGRAPHY; RISK; UTERINE CERVICAL NEOPLASMS;

EID: 84942101410     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01747-15     Document Type: Article

References (59)

1. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3:1151-1157.
2. Guan P, Clifford GM, Franceschi S. 2013. Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies. Int J Cancer 132:248-250. http://dx.doi.org/10.1002/ijc.27663.
3. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. 2011. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927-935. http://dx.doi.org/10.1002/ijc.25396.
4. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A. 2003. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63:7215-7220.
5. De Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Fleuren GJ. 2005. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 114:422-425. http://dx.doi.org/10.1002/ijc.20727.
6. Lizano M, Berumen J, Guido MC, Casas L, Garcia-Carranca A. 1997. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89:1227-1231. http://dx.doi.org/10.1093/jnci/89.16.1227.
7. De la Cruz-Hernandez E, Garcia-Carranca A, Mohar-Betancourt A, Duenas-Gonzalez A, Contreras-Paredes A, Perez-Cardenas E, Herrera-Goepfert R, Lizano-Soberon M. 2005. Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol 86:2459-2468. http://dx.doi.org/10.1099/vir.0.80945-0.
8. Hecht JL, Kadish AS, Jiang G, Burk RD. 1995. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 60:369-376. http://dx.doi.org/10.1002/ijc.2910600317.
9. Rose BR, Thompson CH, Zhang J, Stoeter M, Stephen A, Pfister H, Tattersall MH, Cossart YE. 1997. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol 66:282-289. http://dx.doi.org/10.1006/gyno.1997.4740.
10. Sichero L, Franco EL, Villa LL. 2005. Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 191:739-742. http://dx.doi.org/10.1086/427825.
11. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB. 2007. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 16:4-10. http://dx.doi.org/10.1158/1055-9965.EPI-06-0670.
12. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, ter Meulen J, Villa LL. 1993. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67:6424-6431.
13. Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. 2013. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One 8:e72565. http://dx.doi.org/10.1371/journal.pone.0072565.
14. Burk RD, Harari A, Chen Z. 2013. Human papillomavirus genome variants. Virology 445:232-243. http://dx.doi.org/10.1016/j.virol.2013.07.018.
15. Alibegashvili T, Clifford GM, Vaccarella S, Baidoshvili A, Gogiashvili L, Tsagareli Z, Kureli I, Snijders PJ, Heideman DA, van Kemenade FJ, Meijer CJ, Kordzaia D, Franceschi S. 2011. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiol 35:465-470. http://dx.doi.org/10.1016/j.canep.2010.12.006.
16. Aruhuri B, Tarivonda L, Tenet V, Sinha R, Snijders PJ, Clifford G, Pang J, McAdam M, Meijer CJ, Frazer IH, Franceschi S. 2012. Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Cancer Prev Res 5:746-753. http://dx.doi.org/10.1158/1940-6207.CAPR-11-0515.
17. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, Kupryjanczyk J, Krynicki R, Jonska-Gmyrek J, Danska-Bidzinska A, Snijders PJ, Meijer CJ, Zatonski W, Franceschi S. 2008. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44:557-564. http://dx.doi.org/10.1016/j.ejca.2007.12.001.
18. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
19. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991-998. http://dx.doi.org/10.1016/S0140-6736(05)67069-9.
20. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S. 2006. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 95:96-101. http://dx.doi.org/10.1038/sj.bjc.6603208.
21. De Vuyst H, Ndirangu G, Moodley M, Tenet V, Estambale B, Meijer CJ, Snijders PJ, Clifford G, Franceschi S. 2012. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer 131:949-955. http://dx.doi.org/10.1002/ijc.26470.
22. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M. 2008. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 17:1731-1738. http://dx.doi.org/10.1158/1055-9965.EPI-07-2796.
23. Foliaki S, Brewer N, Pearce N, Snijders PJ, Meijer CJ, Waqatakirewa L, Clifford GM, Franceschi S. 2014. Prevalence of HPV infection and other risk factors in a Fijian population. Infect Agents Cancer 9:14. http://dx.doi.org/10.1186/1750-9378-9-14.
24. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Munoz N, Meijer CJ, Herrero R. 2003. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 107:127-133. http://dx.doi.org/10.1002/ijc.11350.
25. Halec G, Schmitt M, Dondog B, Sharkhuu E, Wentzensen N, Gheit T, Tommasino M, Kommoss F, Bosch FX, Franceschi S, Clifford G, Gissmann L, Pawlita M. 2013. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 132:63-71. http://dx.doi.org/10.1002/ijc.27605.
26. Hammouda D, Munoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, Djedeat B, Fontaniere B, Snijders P, Meijer C, Franceschi S. 2005. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 113:483-489. http://dx.doi.org/10.1002/ijc.20600.
27. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S. 2009. HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer 101:202-208. http://dx.doi.org/10.1038/sj.bjc.6605140.
28. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, Bathija H, Heideman DA, van Kemenade FJ, Meijer CJ, Hosseini SJ, Franceschi S. 2012. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer 131:E156-E161. http://dx.doi.org/10.1002/ijc.26488.
29. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, Franceschi S. 2006. Human papillomavirus infection in Shenyang City, People's Republic of China: a populationbased study. Br J Cancer 95:1593-1597. http://dx.doi.org/10.1038/sj.bjc.6603450.
30. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527. http://dx.doi.org/10.1056/NEJMoa021641.
31. Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, Meijer CJ, Clifford GM. 2010. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agents Cancer 5:24. http://dx.doi.org/10.1186/1750-9378-5-24.
32. Raza SA, Franceschi S, Pallardy S, Malik FR, Avan BI, Zafar A, Ali SH, Pervez S, Serajuddaula S, Snijders PJ, van Kemenade FJ, Meijer CJ, Shershah S, Clifford GM. 2010. Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer 102:1657-1660. http://dx.doi.org/10.1038/sj.bjc.6605664.
33. Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygard M, Karki BS, Snijders PJ, Meijer CJ, Franceschi S. 2010. Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control 21:323-330. http://dx.doi.org/10.1007/s10552-009-9467-z.
34. Tshomo U, Franceschi S, Dorji D, Baussano I, Tenet V, Snijders PJ, Meijer CJ, Bleeker MC, Gheit T, Tommasino M, Clifford GM. 2014. Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis 14:408. http://dx.doi.org/10.1186/1471-2334-14-408.
35. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S. 2007. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 121:1306-1311. http://dx.doi.org/10.1002/ijc.22726.
36. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779-787. http://dx.doi.org/10.1128/JCM.40.3.779-787.2002.
37. Cole ST, Danos O. 1987. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol 193:599-608.
38. Meissner J. 1997. Sequencing errors in reference HPV clones, p III-110-III-123. In Myers G, Sverdrup F, Baker C, McBride A, Munger K, Bernard H-U, Meissner J (ed), Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM.
39. Van Doorslaer K, Tan Q, Xirasagar S, Bandaru S, Gopalan V, Mohamoud Y, Huyen Y, McBride AA. 2013. The papillomavirus episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res 41:D571-D578. http://dx.doi.org/10.1093/nar/gks984.
40. Arias-Pulido H, Peyton CL, Torrez-Martinez N, Anderson DN, Wheeler CM. 2005. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology 338:22-34. http://dx.doi.org/10.1016/j.virol.2005.04.022.
41. Vrtacnik Bokal E, Kocjan BJ, Poljak M, Bogovac Z, Jancar N. 2010. Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. J Obstet Gynaecol Res 36:1204-1213. http://dx.doi.org/10.1111/j.1447-0756.2010.01316.x.
42. Arroyo SL, Basaras M, Arrese E, Hernaez S, Andia D, Esteban V, Garcia-Etxebarria K, Jugo BM, Cisterna R. 2012. Human papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain. Virol J 9:258. http://dx.doi.org/10.1186/1743-422X-9-258.
43. Cerqueira DM, Raiol T, Veras NM, von Gal Milanezi N, Amaral FA, de Macedo Brigido M, Martins CR. 2008. New variants of human papillomavirus type 18 identified in central Brazil. Virus Genes 37:282-287. http://dx.doi.org/10.1007/s11262-008-0263-8.
44. Ong CK, Nee S, Rambaut A, Bernard HU, Harvey PH. 1997. Elucidating the population histories and transmission dynamics of papillomaviruses using phylogenetic trees. J Mol Evol 44:199-206. http://dx.doi.org/10.1007/PL00006136.
45. Perez S, Cid A, Inarrea A, Pato M, Lamas MJ, Couso B, Gil M, Alvarez MJ, Rey S, Lopez-Miragaya I, Melon S, Ona M. 2014. Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain. PLoS One 9:e104678. http://dx.doi.org/10.1371/journal.pone.0104678.
46. Pista A, Oliveira A, Barateiro A, Costa H, Verdasca N, Paixao MT. 2007. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J Med Virol 79:1889-1897. http://dx.doi.org/10.1002/jmv.21002.
47. Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, Bacon M, Levine AM, Anastos K, Gange SJ, Watts DH, Da Costa MM, Chen Z, Bang JY, Fazzari M, Hall C, Strickler HD. 2005. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol 86:2709-2720. http://dx.doi.org/10.1099/vir.0.81060-0.
48. Sun Z, Liu J, Wang G, Zhou W, Liu C, Ruan Q. 2012. Variant lineages of human papillomavirus type 18 in northeast China populations characterized by sequence analysis of E6, E7, and L1 regions. Int J Gynecol Cancer 22:930-936. http://dx.doi.org/10.1097/IGC.0b013e318253a994.
49. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968.
50. Yang L, Yang H, Wu K, Shi X, Ma S, Sun Q. 2014. Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in south west China. J Med Virol 86:1926-1936. http://dx.doi.org/10.1002/jmv.24043.
51. Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM, IARC HPV Variant Study Group. 2012. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol 86:6855-6861. http://dx.doi.org/10.1128/JVI.00483-12.
52. Chen AA, Heideman DA, Boon D, Chen Z, Burk RD, De Vuyst H, Gheit T, Snijders PJ, Tommasino M, Franceschi S, Clifford GM. 2014. Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer. Virology 448:356-362. http://dx.doi.org/10.1016/j.virol.2013.10.033.
53. Chen AA, Heideman DA, Boon D, Gheit T, Snijders PJ, Tommasino M, Franceschi S, Clifford GM, IARC HPV Variant Study Group. 2014. Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J Virol 88:4514-4521. http://dx.doi.org/10.1128/JVI.03534-13.
54. Lurchachaiwong W, Junyangdikul P, Termrungruanglert W, Payungporn S, Sampatanukul P, Tresukosol D, Niruthisard S, Trivijitsilp P, Karalak A, Swangvaree S, Poovorawan Y. 2010. Whole-genome sequence analysis of human papillomavirus type 18 from infected Thai women. Intervirology 53:161-166. http://dx.doi.org/10.1159/000274977.
55. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD. 2010. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70:3159-3169. http://dx.doi.org/10.1158/0008-5472.CAN-09-4179.
56. Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutsky LA. 2006. Human papillomavirus type 16 and 18 variants: racerelated distribution and persistence. J Natl Cancer Inst 98:1045-1052. http://dx.doi.org/10.1093/jnci/djj297.
57. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. 2007. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763-1768. http://dx.doi.org/10.1002/ijc.22481.
58. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B. 2004. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 74:107-116. http://dx.doi.org/10.1002/jmv.20153.
59. Pim D, Bergant M, Boon SS, Ganti K, Kranjec C, Massimi P, Subbaiah VK, Thomas M, Tomaic V, Banks L. 2012. Human papillomaviruses and the specificity of PDZ domain targeting. FEBS J 279:3530-3537. http://dx.doi.org/10.1111/j.1742-4658.2012.08709.x.